aluates Reports

$ 0.0

Automative

Global Non-invasive Cancer Diagnosis Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-17Y3136

Global Non invasive Cancer Diagnosis Market Insights and Forecast to 2028

BUY CHAPTERS

Global Non-invasive Cancer Diagnosis Market Research Report 2024

Code: QYRE-Auto-17Y3136

Report

August 2024

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gen-Probe Inc

A&G Pharmaceutical

Affymetrix Inc

Digene Corporation

Quest Diagnostics Inc.

BioView

LabCorp

Aviva Biosciences Corporation

Precision Therapeutics

Non-invasive Cancer Diagnosis Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Non-invasive Cancer Diagnosis Market

The global Non-invasive Cancer Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-invasive Cancer Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Cancer Diagnosis.

Report Scope

The Non-invasive Cancer Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-invasive Cancer Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-invasive Cancer Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-invasive Cancer Diagnosis Market Report

Report Metric	Details
Report Name	Non-invasive Cancer Diagnosis Market
CAGR	5%
Segment by Type	Clinical Chemistry Immunochemistry/Immunoassay Molecular Diagnostics Others
Segment by Application	Blood Cancer Solid Tumors Breast Cancer Lung Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gen-Probe Inc., A&G Pharmaceutical, Affymetrix Inc., Digene Corporation, Quest Diagnostics Inc., BioView Inc., LabCorp, AVIVA Biosciences Corporation, Precision Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-invasive Cancer Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-invasive Cancer Diagnosis Market report?

Ans: The main players in the Non-invasive Cancer Diagnosis Market are Gen-Probe Inc., A&G Pharmaceutical, Affymetrix Inc., Digene Corporation, Quest Diagnostics Inc., BioView Inc., LabCorp, AVIVA Biosciences Corporation, Precision Therapeutics

What are the Application segmentation covered in the Non-invasive Cancer Diagnosis Market report?

Ans: The Applications covered in the Non-invasive Cancer Diagnosis Market report are Blood Cancer, Solid Tumors, Breast Cancer, Lung Cancer, Others

What are the Type segmentation covered in the Non-invasive Cancer Diagnosis Market report?

Ans: The Types covered in the Non-invasive Cancer Diagnosis Market report are Clinical Chemistry, Immunochemistry/Immunoassay, Molecular Diagnostics, Others

Recommended Reports

Cancer Diagnostics

Non-Invasive Testing

Cancer Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Clinical Chemistry

1.2.3 Immunochemistry/Immunoassay

1.2.4 Molecular Diagnostics

1.2.5 Others

1.3 Market by Application

1.3.1 Global Non-invasive Cancer Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Blood Cancer

1.3.3 Solid Tumors

1.3.4 Breast Cancer

1.3.5 Lung Cancer

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-invasive Cancer Diagnosis Market Perspective (2019-2030)

2.2 Non-invasive Cancer Diagnosis Growth Trends by Region

2.2.1 Global Non-invasive Cancer Diagnosis Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-invasive Cancer Diagnosis Historic Market Size by Region (2019-2024)

2.2.3 Non-invasive Cancer Diagnosis Forecasted Market Size by Region (2025-2030)

2.3 Non-invasive Cancer Diagnosis Market Dynamics

2.3.1 Non-invasive Cancer Diagnosis Industry Trends

2.3.2 Non-invasive Cancer Diagnosis Market Drivers

2.3.3 Non-invasive Cancer Diagnosis Market Challenges

2.3.4 Non-invasive Cancer Diagnosis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-invasive Cancer Diagnosis Players by Revenue

3.1.1 Global Top Non-invasive Cancer Diagnosis Players by Revenue (2019-2024)

3.1.2 Global Non-invasive Cancer Diagnosis Revenue Market Share by Players (2019-2024)

3.2 Global Non-invasive Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Non-invasive Cancer Diagnosis Revenue

3.4 Global Non-invasive Cancer Diagnosis Market Concentration Ratio

3.4.1 Global Non-invasive Cancer Diagnosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Cancer Diagnosis Revenue in 2023

3.5 Non-invasive Cancer Diagnosis Key Players Head office and Area Served

3.6 Key Players Non-invasive Cancer Diagnosis Product Solution and Service

3.7 Date of Enter into Non-invasive Cancer Diagnosis Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-invasive Cancer Diagnosis Breakdown Data by Type

4.1 Global Non-invasive Cancer Diagnosis Historic Market Size by Type (2019-2024)

4.2 Global Non-invasive Cancer Diagnosis Forecasted Market Size by Type (2025-2030)

5 Non-invasive Cancer Diagnosis Breakdown Data by Application

5.1 Global Non-invasive Cancer Diagnosis Historic Market Size by Application (2019-2024)

5.2 Global Non-invasive Cancer Diagnosis Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-invasive Cancer Diagnosis Market Size (2019-2030)

6.2 North America Non-invasive Cancer Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Non-invasive Cancer Diagnosis Market Size by Country (2019-2024)

6.4 North America Non-invasive Cancer Diagnosis Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-invasive Cancer Diagnosis Market Size (2019-2030)

7.2 Europe Non-invasive Cancer Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Non-invasive Cancer Diagnosis Market Size by Country (2019-2024)

7.4 Europe Non-invasive Cancer Diagnosis Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-invasive Cancer Diagnosis Market Size (2019-2030)

8.2 Asia-Pacific Non-invasive Cancer Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Region (2019-2024)

8.4 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-invasive Cancer Diagnosis Market Size (2019-2030)

9.2 Latin America Non-invasive Cancer Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Non-invasive Cancer Diagnosis Market Size by Country (2019-2024)

9.4 Latin America Non-invasive Cancer Diagnosis Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-invasive Cancer Diagnosis Market Size (2019-2030)

10.2 Middle East & Africa Non-invasive Cancer Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Country (2019-2024)

10.4 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Gen-Probe Inc.

11.1.1 Gen-Probe Inc. Company Detail

11.1.2 Gen-Probe Inc. Business Overview

11.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Introduction

11.1.4 Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2019-2024)

11.1.5 Gen-Probe Inc. Recent Development

11.2 A&G Pharmaceutical

11.2.1 A&G Pharmaceutical Company Detail

11.2.2 A&G Pharmaceutical Business Overview

11.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Introduction

11.2.4 A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2019-2024)

11.2.5 A&G Pharmaceutical Recent Development

11.3 Affymetrix Inc.

11.3.1 Affymetrix Inc. Company Detail

11.3.2 Affymetrix Inc. Business Overview

11.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Introduction

11.3.4 Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2019-2024)

11.3.5 Affymetrix Inc. Recent Development

11.4 Digene Corporation

11.4.1 Digene Corporation Company Detail

11.4.2 Digene Corporation Business Overview

11.4.3 Digene Corporation Non-invasive Cancer Diagnosis Introduction

11.4.4 Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2019-2024)

11.4.5 Digene Corporation Recent Development

11.5 Quest Diagnostics Inc.

11.5.1 Quest Diagnostics Inc. Company Detail

11.5.2 Quest Diagnostics Inc. Business Overview

11.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Introduction

11.5.4 Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2019-2024)

11.5.5 Quest Diagnostics Inc. Recent Development

11.6 BioView Inc.

11.6.1 BioView Inc. Company Detail

11.6.2 BioView Inc. Business Overview

11.6.3 BioView Inc. Non-invasive Cancer Diagnosis Introduction

11.6.4 BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2019-2024)

11.6.5 BioView Inc. Recent Development

11.7 LabCorp

11.7.1 LabCorp Company Detail

11.7.2 LabCorp Business Overview

11.7.3 LabCorp Non-invasive Cancer Diagnosis Introduction

11.7.4 LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2019-2024)

11.7.5 LabCorp Recent Development

11.8 AVIVA Biosciences Corporation

11.8.1 AVIVA Biosciences Corporation Company Detail

11.8.2 AVIVA Biosciences Corporation Business Overview

11.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Introduction

11.8.4 AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2019-2024)

11.8.5 AVIVA Biosciences Corporation Recent Development

11.9 Precision Therapeutics

11.9.1 Precision Therapeutics Company Detail

11.9.2 Precision Therapeutics Business Overview

11.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Introduction

11.9.4 Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2019-2024)

11.9.5 Precision Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Gen-Probe Inc

A&G Pharmaceutical

Affymetrix Inc

Digene Corporation

Quest Diagnostics Inc.

BioView

LabCorp

Aviva Biosciences Corporation

Precision Therapeutics

List of Tables

Table 1. Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Clinical Chemistry

Table 3. Key Players of Immunochemistry/Immunoassay

Table 4. Key Players of Molecular Diagnostics

Table 5. Key Players of Others

Table 6. Global Non-invasive Cancer Diagnosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Non-invasive Cancer Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Non-invasive Cancer Diagnosis Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Non-invasive Cancer Diagnosis Market Share by Region (2019-2024)

Table 10. Global Non-invasive Cancer Diagnosis Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Non-invasive Cancer Diagnosis Market Share by Region (2025-2030)

Table 12. Non-invasive Cancer Diagnosis Market Trends

Table 13. Non-invasive Cancer Diagnosis Market Drivers

Table 14. Non-invasive Cancer Diagnosis Market Challenges

Table 15. Non-invasive Cancer Diagnosis Market Restraints

Table 16. Global Non-invasive Cancer Diagnosis Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Non-invasive Cancer Diagnosis Market Share by Players (2019-2024)

Table 18. Global Top Non-invasive Cancer Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Cancer Diagnosis as of 2023)

Table 19. Ranking of Global Top Non-invasive Cancer Diagnosis Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Non-invasive Cancer Diagnosis Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Non-invasive Cancer Diagnosis Product Solution and Service

Table 23. Date of Enter into Non-invasive Cancer Diagnosis Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Non-invasive Cancer Diagnosis Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Non-invasive Cancer Diagnosis Revenue Market Share by Type (2019-2024)

Table 27. Global Non-invasive Cancer Diagnosis Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Non-invasive Cancer Diagnosis Revenue Market Share by Type (2025-2030)

Table 29. Global Non-invasive Cancer Diagnosis Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Non-invasive Cancer Diagnosis Revenue Market Share by Application (2019-2024)

Table 31. Global Non-invasive Cancer Diagnosis Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Non-invasive Cancer Diagnosis Revenue Market Share by Application (2025-2030)

Table 33. North America Non-invasive Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Non-invasive Cancer Diagnosis Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Non-invasive Cancer Diagnosis Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Non-invasive Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Non-invasive Cancer Diagnosis Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Non-invasive Cancer Diagnosis Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Non-invasive Cancer Diagnosis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Non-invasive Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Non-invasive Cancer Diagnosis Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Non-invasive Cancer Diagnosis Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Country (2025-2030) & (US$ Million)

Table 48. Gen-Probe Inc. Company Detail

Table 49. Gen-Probe Inc. Business Overview

Table 50. Gen-Probe Inc. Non-invasive Cancer Diagnosis Product

Table 51. Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2019-2024) & (US$ Million)

Table 52. Gen-Probe Inc. Recent Development

Table 53. A&G Pharmaceutical Company Detail

Table 54. A&G Pharmaceutical Business Overview

Table 55. A&G Pharmaceutical Non-invasive Cancer Diagnosis Product

Table 56. A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2019-2024) & (US$ Million)

Table 57. A&G Pharmaceutical Recent Development

Table 58. Affymetrix Inc. Company Detail

Table 59. Affymetrix Inc. Business Overview

Table 60. Affymetrix Inc. Non-invasive Cancer Diagnosis Product

Table 61. Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2019-2024) & (US$ Million)

Table 62. Affymetrix Inc. Recent Development

Table 63. Digene Corporation Company Detail

Table 64. Digene Corporation Business Overview

Table 65. Digene Corporation Non-invasive Cancer Diagnosis Product

Table 66. Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2019-2024) & (US$ Million)

Table 67. Digene Corporation Recent Development

Table 68. Quest Diagnostics Inc. Company Detail

Table 69. Quest Diagnostics Inc. Business Overview

Table 70. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Product

Table 71. Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2019-2024) & (US$ Million)

Table 72. Quest Diagnostics Inc. Recent Development

Table 73. BioView Inc. Company Detail

Table 74. BioView Inc. Business Overview

Table 75. BioView Inc. Non-invasive Cancer Diagnosis Product

Table 76. BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2019-2024) & (US$ Million)

Table 77. BioView Inc. Recent Development

Table 78. LabCorp Company Detail

Table 79. LabCorp Business Overview

Table 80. LabCorp Non-invasive Cancer Diagnosis Product

Table 81. LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2019-2024) & (US$ Million)

Table 82. LabCorp Recent Development

Table 83. AVIVA Biosciences Corporation Company Detail

Table 84. AVIVA Biosciences Corporation Business Overview

Table 85. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product

Table 86. AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2019-2024) & (US$ Million)

Table 87. AVIVA Biosciences Corporation Recent Development

Table 88. Precision Therapeutics Company Detail

Table 89. Precision Therapeutics Business Overview

Table 90. Precision Therapeutics Non-invasive Cancer Diagnosis Product

Table 91. Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2019-2024) & (US$ Million)

Table 92. Precision Therapeutics Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-invasive Cancer Diagnosis Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Non-invasive Cancer Diagnosis Market Share by Type: 2023 VS 2030

Figure 3. Clinical Chemistry Features

Figure 4. Immunochemistry/Immunoassay Features

Figure 5. Molecular Diagnostics Features

Figure 6. Others Features

Figure 7. Global Non-invasive Cancer Diagnosis Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Non-invasive Cancer Diagnosis Market Share by Application: 2023 VS 2030

Figure 9. Blood Cancer Case Studies

Figure 10. Solid Tumors Case Studies

Figure 11. Breast Cancer Case Studies

Figure 12. Lung Cancer Case Studies

Figure 13. Others Case Studies

Figure 14. Non-invasive Cancer Diagnosis Report Years Considered

Figure 15. Global Non-invasive Cancer Diagnosis Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Non-invasive Cancer Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Non-invasive Cancer Diagnosis Market Share by Region: 2023 VS 2030

Figure 18. Global Non-invasive Cancer Diagnosis Market Share by Players in 2023

Figure 19. Global Top Non-invasive Cancer Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Cancer Diagnosis as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Non-invasive Cancer Diagnosis Revenue in 2023

Figure 21. North America Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Non-invasive Cancer Diagnosis Market Share by Country (2019-2030)

Figure 23. United States Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Non-invasive Cancer Diagnosis Market Share by Country (2019-2030)

Figure 27. Germany Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Non-invasive Cancer Diagnosis Market Share by Region (2019-2030)

Figure 35. China Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Non-invasive Cancer Diagnosis Market Share by Country (2019-2030)

Figure 43. Mexico Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Non-invasive Cancer Diagnosis Market Share by Country (2019-2030)

Figure 47. Turkey Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Non-invasive Cancer Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Gen-Probe Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2019-2024)

Figure 50. A&G Pharmaceutical Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2019-2024)

Figure 51. Affymetrix Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2019-2024)

Figure 52. Digene Corporation Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2019-2024)

Figure 53. Quest Diagnostics Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2019-2024)

Figure 54. BioView Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2019-2024)

Figure 55. LabCorp Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2019-2024)

Figure 56. AVIVA Biosciences Corporation Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2019-2024)

Figure 57. Precision Therapeutics Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Immuno oncology Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Diagnostic Kit Market Research Report 2024

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024

Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Tissue Diagnostics Market Research Report 2024

Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Precision Diagnostic Market Research Report 2024

Next Generation Breast Cancer Diagnostic and Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Cancer Diagnosis Market Research Report 2025

Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Muscle Invasive Bladder Cancer Treatment Market Research Report 2024

Non Invasive Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Based Molecular Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Non Small Cell Lung Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non melanoma Skin Cancer Drugs Market Research Report 2024

Global Lung Cancer Diagnostic Tests Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions